Food | Page 154 of 210 | SpiritIndia.com

Health :: Abbott to Expand Presence in Lipid Management Market with Acquisition of Kos Pharmaceuticals

Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.

Schizophrenia :: Barr Receives Tentative Approval for a Generic Version of ZYPREXA, Zydis

Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Eli Lilly and Company’s ZYPREXA(R) Zydis(R) (Olanzapine) Orally Disintegrating Tablets, 5mg, 10mg, 15mg and 20mg.

Pain :: Tarantula Venom And Chili Peppers Target Same Pain Sensor

Venom from a West Indian tarantula has been shown to cause pain by exciting the same nerve cells in mice that sense high temperatures and the hot, spicy ingredient in chili peppers, UCSF scientists have discovered.

Restless Legs Syndrome :: Boehringer Ingelheim?s pramipexole for the treatment of Restless Legs Syndrome RLS

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS).1 This is an important milestone for pramipexole (Mirapexin? / Sifrol? / Mirapex?), which was already approved throughout the European Union in April 2006 for this second indication.

Health :: Cooking, Cleaning Important in Commander-in-Chief’s Kitchen

George Washington’s favorite foods were ice cream and fish. Abraham Lincoln enjoyed fruit salad, cheese and crackers. John F. Kennedy loved New England Clam Chowder, and George W. Bush is a big fan of Mexican food.

FDA :: Actions Program for Medical Devices – Enhancing Patient Safety

The U.S. Food and Drug Administration (FDA) today announced its action plan for strengthening the way it monitors the safety of medical devices after they reach the marketplace.

Health :: Food Safety Consortium Summarizes Year’s Work

Multiple research projects across three cooperating universities are demonstrating progress that is enabling American producers, processors and consumers to maintain a safe food supply. The Food Safety Consortium summarized that work in its recently completed annual report for the 2005-06 fiscal year.

Child Care :: Violent spell rivals worst times for Palestinian children

UNICEF is distressed by the extraordinary violence in northern Gaza. Since 1 November, we estimate that 68 Palestinians have been killed, including 14 children. The deaths during the last seven days, including the children killed in today’s shelling, add to the steady deadly toll on Palestinian children since the Intifada broke out in 2000, with 113 children killed so far this year. This is more than double the total figure for 2005.

Health :: WFP hails Russian Federation US$2 million donation for Kenya drought

WFP has welcomed a generous contribution of US$2 million from the Russian Federation to WFP?s emergency operation in Kenya, praising the first donation from the Russian Federation to WFP?s work in East Africa.

Osteosarcoma :: IDM Pharma’s Mepact, mifamurtide – Junovan in the Treatment of Osteosarcoma

IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted a Marketing Authorization Application (MAA) in eCTD format (electronic common technical document) to the European Medicines Agency (EMEA) for Mepact (mifamurtide for injection), requesting approval for its use in the treatment of patients with newly diagnosed resectable high-grade osteosarcoma following surgical resection in combination with post-operative multi-agent chemotherapy. This announcement follows the October 25, 2006 submission of a New Drug Application (NDA) for Junovan (mifamurtide for injection) to the Food and Drug Administration (FDA) in the United States.